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ABSTRACT 
Objective: The aim of this study was to optimize pantoprazole enteric coating process based on Quality by Design (QbD) principle and successful 
scale up.  
Methods: The critical process parameters (CPP) were identified based on Failure Mode and Effect Analysis (FMEA) tool. A full factorial design was 
applied to develop design space and determine control strategy for pantoprazole enteric coating process, have promising yield, assay and reduced 
process time. The coating process variables studied were air volume (X1), spray rate (X2) and atomization air pressure (X3), versus percentage fines 
(Y1), percentage agglomerates (Y2) and assay (Y3) as responses. The pellets were coated in Wurster and characterized for assay, dissolution, 
scanning electron microscopy and loss on drying. 
Results: When X2 at low level and X3 at high level, spray drying increased hence fines increased while X2 at a high level and X3 at a low level, 
agglomeration increased. The optimization performed to decide level of X2 and X3 for fines and agglomerated free process. The operating ranges, for 
robust coating process of desired pellets yield and quality, X1, X2 and X3 were 46-58 CFM, 6-9 g/min and 1.1-1.3 bar respectively. In scale up of 
pellets, physical and chemical parameters reproduced based on process ran as per scale up factor calculation.  
Conclusion: It was concluded that a promising pellets coating process was successfully designed using QbD approach and successfully scale upscale 
up possible based on complete optimization of process variables, understanding of risk associated with variables and implementation of scale-up 
factor calculation provided by the vendor.  
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INTRODUCTION 
As the pharmaceutical industry tries to embrace the methodologies 
of quality by design (QbD) provided by the FDA’s process validation 
(PV) guidance [1] and International Conference on Harmonization 
(ICH) Q8/Q9/Q10 [2-4], many companies are challenged by the 
evolving concept of criticality as applied to quality attributes and 
process parameters. 
ICH Q8 (R2) explained the Critical Process Parameter (CPP)-A 
process parameter whose variability has an impact on a critical 
quality attribute (CQA) and therefore, should be monitored or 
controlled to ensure the process produces the desired quality [2]. 
The CPP states that a parameter is considered critical when its 
variability has an impact on a CQA. The amount of impact is not 
defined, which leads to the question, does even a small impact to a 
CQA mean that the parameter is critical? It is not difficult to imagine 
the example of an extreme shift of a process parameter having a 
minor impact on a CQA, whether measurable or not [1]. CPP 
selection has traditionally been difficult because of a lack of a 
systematic approach to the problem which due to a large number of 
unit operations and complexity. Failure to identify critical 
parameters can result in unexplainable variation during batch 
processing and lot acceptance [5]. 
The pellets coating in the bottom spray is considered very critical 
process than other pelletization techniques because it involved 
number of process variables which are directly or indirectly 
affecting the product quality. As per the literature, there are 
selected potential process parameters-product temperature [6-8], 
humidity [9], inlet air flow [10-11], atomization air pressure [12-
14], spray rate [14,16], column height [11,17-18] responsible for 
the product quality however others like nozzle tip diameter, filter 
bags type and drying time are also important based on practical 
experience. 
The FMEA is the best risk management tool can used for Wurster 
based pellet coating process to categories the risk of process 
variables. The risk of each failure is prioritized based on the risk 
priority number (RPN). RPN is a decision factor based on three 
ratings: Severity (S), Occurrence (O) and Detection (D). These 
ratings are scaled with numbers between 1 and 10 [19]. Risk 
Priority Number, which is the product of the severity, occurrence 
and detection ratings is calculated as RPN = S x O x D. The RPN must 
be calculated for each cause of failure. RPN shows the relative 
likelihood of a failure mode, in that the higher number, the higher 
the failure mode. From RPN, a critical summary can be drawn up to 
highlight the areas where the action is mostly needed [20]. Risk 
priority numbers (RPNs) were calculated as the product of 
occurrence, severity and detectability scores. Failure mode scores 
could range from 1 to 1000 [21]. We ranked S, O and D of 1-3 as 
best-case value, 4-7 as moderate-case value and 8-10 as worst-case 
value, and then a maximum RPN of 1000 and a minimum RPN of 1 
are possible. 
In this study pantoprazole enteric coated pellets used to prepare oro 
dispersible multiunit particulate system (MUPS) tablet of 
pantoprazole where enteric coating was a functional coating which 
decided the acid resistance capacity of pellets. Not only optimization 
of formulation variables (performed in previous work) required in 
this case but optimization of coating processes also the potential 
impact on pellets quality.  
Successful pellet coating process optimization at lab level using 
small scale Wurster is half work done. Successful scale-up of 
Wurster based coating process at commercial scale is a challenging 
task. Nowadays USFDA also demanding for a scientific approach for 
scale activity based on development batches. In one of the USFDA's 
guide to inspections report pre/post approval issues explained the 
expectations of regulatory authority on scale up activity said-it is 
important that the development and scale-up of the process be well 
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documented so that a link between the bio/clinical batches and the 
commercial process can be established [22]. 
Scale up/pilot batches perform in single Wurster. The development 
of the product is normally done in 6" Wurster with the batch size 0.5 
to 1.5 kg where Wurster column and spray nozzle is small hence 
overall coating zone is small. The recommended pilot model is 18" 
Wurster where the Wurster column and base plate are much larger. 
From the lab to pilot although there is single spray nozzle, but the 
nozzle is much bigger and can permit higher spray rate. The batch 
depth and mass flow density increases. Overall, the coating zone 
increases from lab to pilot scale. The overall coating zone will 
remain same in the pilot and commercial scale except the height of 
the Wurster column. Therefore, the base area of Wurster column 
plays important role in efficient coating. All process parameters 
should be proportional to the base area of Wurster column 
compared with lab model column.  
All the process variables again show their significance in scale up 
model also. Nevertheless, once the effect of variables are studied and 
understood in lab model, it will make the analysis much easier. Just 
like the variables remaining same in pilot scale also, the same 
process control will apply. Only the unknown factor will be the mass 
effect. As in the lab scale, one has to follow sequential approach to 
set the parameter for the scale up.  
The aim of this study was to investigate the influence of process 
parameters on the pellets quality using an experimental design and 
risk mitigation performed based on QbD principles for quality 
product. Successful scale-up of pellets coating process performed 
based on process optimization conducted at lab scale equipment. 
Here attempt to help the industry to plan scale up activity in linear 
as the demand of regulatory authority to prove extrapolation of 
design space in commercial scale or in post-approval changes stage.  
MATERIALS AND METHODS 
Materials 
Pantoprazole sodium sesquihydrate was gifted from Hetero drugs. 
Methacrylic Acid Copolymer Dispersion (Eudragit® L30D-55, 
Evonik) and PlasACRYL® HTP20 (Emerson) were gifted from 
Evonik, India. 
Methods 
Preparation of enteric coated pellets 
Weighed quantity of PlasACRYL HTP20 was dispersed and shaken 
well in the container to get a homogenous dispersion. Separately 
Eudragit L30D-55 dispersion was made, to this PlasACRYL HTP20 
dispersion was added under slow stirring followed by addition of 
purified water. The dispersion had stirred for 30 min using 
mechanical stirrer (Remi Elektrotechnik Ltd, India) and strained 
through 100 mesh screens. Accurately weighed 500 gm of seal 
coated pellets were loaded in Wurster (Pam GPCG 1.1) and preceded 
at suitable process parameters using this coating mixture. 
Process variables involved in Wurster based pellets coating 
process 
There are five sets of process variables involved in Wurster based 
pellets coating process equipment variables, solution/dispersion 
preparation variables, preheating variables, spraying variables and 
drying variables. The variables come under each set provided in fig. 1. 
The process variables categorization and risk identification 
performed based on previous experience and literature before 
conducting the preliminary trials.  
Preliminary trials 
Initial trials were performed by varying the process parameters to 
understand the impact on product quality. Enteric coating is a 
functional coating which is one of the critical processes in the 
manufacturing of MUPS PTZ tablet. We varied the levels of all 
process parameters mentioned in table 1 and concluded the selected 
critical process parameters (CPPs) which needs systemic 
optimization plan to reduce the risk. 
 
Fig. 1: Process variables involved in Wurster based pellets 
coating process 
 
Table 1: Process parameters for enteric coating of preliminary 
trials 
Process parameters Values 
Batch Size 600 gm 
Air distribution plate B 
Wurster column height 12-18 mm 
Nozzle tip diameter 1.0 mm 
Filter porosity 100 µ 
Product temperature 25-32 °C 
Atomization air pressure 0.9-1.4 bar 
Spray rate 4-10 g/min 
Air volume 45-70 cfm 
LOD NMT 1.5 % 
 
Characterization of pellets 
Assay 
Enteric coated pellets assay were performed as per Pantoprazole 
Sodium Delayed-Release Tablets USP monograph [23]. 
Dissolution studies 
Dissolution studies were carried out in two stages. Dissolution in 
acidic condition, i.e., simulated stomach condition was performed in 
USP apparatus II, dissolution medium used was 1000 ml of 0.1 N 
hydrochloric acid at a speed 75 rpm and temperature 37±0.5 oC for 
120 min followed by dissolution in simulated intestinal condition 
using USP apparatus II, dissolution medium used was 1000 ml of 
phosphate buffer pH 6.8 at a speed 75 rpm and temperature 37±0.5 
oC for 30 min. 
Scanning electron microscopy 
Enteric coated pellets were placed onto a double-sided carbon tape 
mounted on studs and sputter-coated (JFC-1100, Jeol, Tokyo, Japan) 
with gold. Photomicrographs of gold coated enteric coated pellets 
were obtained using a scanning electron microscope (SEM; Phenom, 
Netherlands).  
Loss on drying (LOD) 
Accurately weighed pellets (1.5 to 2 gm) were placed on tare 
aluminium plate of moisture balance (Mettler Toledo HR83P). The 
test was performed at a temperature 105 °C till a constant weight 
was achieved. The reading displayed on the screen was noted as the 
LOD of the sample.  
Initial risk assessment of coating process 
Initial risk assessment performed using FMEA tool. The pareto 
chart was plotted of process variables vs RPN. The initial risk 
assessment of the enteric coating process presented in fig. 2 
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identified the risk of the enteric coating step to impact yield and 
drug release from the drug product as high. Process variables 
that could potentially impacted enteric coating process were 
identified and their associated risk was evaluated based on 
preliminary trials. Conducting design of experiments (DoE) to 
evaluate all the variables involved in a Wurster coating process 
is not feasible. 
 
 
Fig. 2: Pareto chart showing RPN scores for the coating process 
parameters for pantoprazole enteric coated pellets before and 
after risk mitigation 
 
Therefore, variables ranked based on RPN value. The RPN threshold 
below 60 ranked low risk, 60-80 ranked medium risk and above 80 
ranked high-risk process variables.  
The variables ranked as high risk i.e. Air volume, spray rate and 
atomization air pressure, and were evaluated by conducting DoE 
studies to gain process understanding and remaining kept constant.  
Identification of CQAs 
The aim of this work was to decide the ranges of CPPs involved in 
enteric coating process. Yield is an important quality attributes. In 
pellet formulation, yield is reduced either due to fine generation or 
agglomerates formed. In this study, % fines (<355μm) and % 
agglomerate (>600μm) selected as intermediated CQAs which 
directly related to yield. For chemical characterization, assay is the 
best test to conclude quality of coating, which is another CQA. 
Impact of process variables on dissolution in acidic condition 
already studies in preliminary trial and concluded variation in 
process parameters no affect on dissolution. 
Screening of design of experiments 
Prior to optimization, historical data were analyzed and several 
screening DoE analyses were done. A 23 full factorial design with 
two center points was performed to screen the effect of process 
parameters on yield and assay to explore the quadratic response 
surfaces and for constructing a second-order polynomial models 
using Design Expert (Version 8.1.6; Stat-Ease Inc., Minneapolis, 
Minnesota). A design matrix comprising 10 experimental runs 
including 2 centre points was constructed. 
The response (Yi) in each trial was measured by carrying out a 
multiple factorial regression analysis using the quadratic model:  
Yi = b0+b1X1+b2X2+b3X3+b4X1X2+b5X1X3+b6X2X3+b7X12+b8X22+b9X32 
Where Yi is the dependent variable; b0 is the arithmetic mean 
response of all trials; and bi is the estimated coefficient for factor Xi. 
The main effects, X1, X2, and X3, represent the average value of 
changing factor one at a time; X1X2, X1X3, and X2X3 represent the 
interaction terms and the polynomial terms (X12, X22 and X32) are 
used to assess nonlinearity [24]. 
 
Table 2: 23 Full factorial design-Factors, levels and successful operating range 
Independent variables  (Process variables) Unit Levels 
-1 0 1 
X1: Air volume  cfm 46 58 70 
X2: Spray rate  g/min 3 6 9 
X3: Atomization Air Pressure bar 0.8 1.1 1.4 
Dependent variables (CQAs) Unit Successful operating range 
Y1: Fines (<250 µm) % <2 
Y2: Agglomerate (>425 µm) % <2 
Y3: Assay % 95<Y3<105 
The independent variables selected were air volume (X1), spray rate (X2) and atomization air pressure (X3). The dependent variables were release % 
fines (Y1), % agglomerates (Y2) and assay (Y3). The range of independent variables under study is shown in table 2 along with their low, medium, 
and high levels, which were selected based on the results from preliminary experimentation. 
 
Development of design space and control strategy  
The relationship between the process variables and CQAs were 
described in the design space (DS). DS was determined from the 
common region of successful operating ranges for multiple CQAs 
discussed in table 2. It is expected that operation within the DS 
space will result in a product possessing the desired CQAs. 
Optimized process variables set al. so get from this DS. A control 
strategy (CS) is designed to ensure that a product of required quality 
will be produced consistently [2]. The acceptable range of material 
attributes was determined based on DS. LOD of enteric coated 
pellets was targeted less than 1.5% w/w.  
Scale up of pantoprazole enteric coated pellets  
After successful optimization trials, values of CPPs were finalized 
and covered in lab scale CS. In scale up of pellets, CPP needs to frame 
based on linearity function of both i.e. lab scale and 
pilot/commercial scale equipment. Bottom spray fluidized bed 
processor (Wurster technology) supplier always designs all capacity 
equipment in linear scale which help to make scale up activity easy. 
There are some scientific theoretical factors involved in scale up 
activity. We performed to scale up trial in Pam FBE 125C which is 
linear with Pam GPCG 1.1 equipment and comparative pellets 
coating process parameters presented in table 3. 
In Wurster column, 100 % coating process and 70-80% drying process 
completed. So out off whole coating assembly, Wurster column is a 
functional area for quality coating. Wurster column base area 
considered for theoretical factor calculation in scaling up activity. In 
table 3, values of CPPs during lab scale and pilot scale are given. 
RESULTS AND DISCUSSION 
Preliminary trials 
Trials were performed to understand behavior of process 
parameters on pellets quality. Product temperature kept 26-29 °C as 
optimum temperature range to form a film and to run process 
smooth. Above 32 °C, film formation starts in gun and frequently gun 
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choked and below 25 °C, agglomerates formation started due to less 
drying of sprayed dispersion.  
During the preliminary trials for the process, the dew point was 
maintained 8-11°C to reduce static charge generated initially due to 
preheating of seal coated pellets. The spray rate was initially 4 
g/min and was incrementally ramped up during the course of the 
preliminary batch. At 10 g/min, agglomeration was observed, 
suggesting that the spray rate should not exceed 10 g/min. smooth 
spraying was observed at atomization air pressure of 0.9-1.2 bar but 
above 1.4 bars more spray drying occurred. Air volume below 45 
cfm, pellets didn't fluidize properly and above 70 cfm pellets 
impacting on the filter wall and less time spend in Wurster column. 
Spray rate, atomization air pressure, and air volume were the key 
coating process parameters. These parameters were considered as 
process variables for DoE study. 
  
Table 3: Comparative pellets coating process parameters of Pam GPCG 1.1 and pam FBE based on scale up factor 
Parameters Units Pam GPCG 1.1 Scale up factor Pam FBE 125 C 
Equipment parameters 
Wurster column diameter  m 0.072 - 0.219 
Wurster column height m 0.20 - 0.36 
Base plate area m² 0.0145 - 0.1918 
Suitable air distribution plate - B - B-I 
Working volume L 2.4 35 84 
Batch size (preferred) kg 0.6 35 21.0 
Wurster column base area  m² 0.0041 9 0.0377 
Process parameters       
Inlet air temperature  ° C 26-35 - 26-35 
Product temperature  ° C 26-28 - 26-28 
Wurster column height from base plate mm 15-20 - 40-45 
Inlet air volume CFM 9 9 81 
Spray rate g/min 10-20 9 90-180 
Spray gun model - 970/0  940-943/7-1 S91 
Atomization air pressure bar 
(CFM)* 
1.0 (1.2)  9 2.5 (10.8)  
1.5 (1.4)  9  3.0 (12.6)  
2.0 (1.7) 9 4.0 (15.3) 
*bar to CFM calculation performed based on the type of spray gun. CFM value was scaled up.  
 
Experimental design 
The aim of this work was to optimize process variables for enteric 
coated pellets processing. The ideal coating parameters should 
reduced the generation of fines, and agglomerates and maintain the 
uniform enteric coat quality from batch to batch. 
The full factorial design (FFD) is one the most widely used type of 
experimental designs. The results (table 4) showed that the 
percentage fines generation varied from 0.2 to 5.4%, the 
agglomerates generation varied from 0.2 to 7.1% and assay varied 
from 96.8 to 100.1%.  
The wide variation in the percentage fines and agglomerates for 
different formulations and the high degree of reproducibility 
suggested that these responses are strongly dependent on the 
selected independent factors. In case of the assay, although small 
variations were noticed between different formulations, the results 
seemed to be systematic and repeatable, which may suggest 
dependency on the studied factors. 
 
Table 4: Experimental matrix and results 
Trial Process variable (Factors) Responses (CQAs) 
X1 X2 X3 Y1 Y2 Y3 
F11 -1 -1 -1 0.2 0.5 100.1 
F12 1 -1 -1 0.8 0.7 9.7 
F13 -1 1 -1 0.2 7.1 97.8 
F14 1 1 -1 0.4 6.2 97.5 
F15 -1 -1 1 1.2 0.4 96.8 
F16 1 -1 1 5.4 0.4 98.9 
F17 -1 1 1 0.5 0.6 99.6 
F18 1 1 1 0.2 0.4 99.8 
F19 0 0 0 0.2 0.3 99.5 
F20 0 0 0 0.2 0.2 99.8 
 
Trial F15 and F16 showed highest fines generation however, it has 
no effect on pellet surface. In trial F13 and F14, high spray level and 
low atomization air pressure leads to the formation of more 
agglomerates. Comparatively in other trials percentage of 
agglomerates formation was considerably less. The SEM images of 
enteric coated pellets presented in fig. 3.  
Response surface plots interpretation 
The results indicated that the fines (Y1) generation was 
significantly influenced by the linear models of spray rate (X2), 
atomization air pressure (X3) and in small percentage of air 
volume (X1), in addition to the interactive model of the quantity of 
spray rate-atomization air pressure (X2X3). Fig. 4a portray the 
three-dimensional surface plot indicated that when X3 increased 
from-1 level to+1 level, Y1 was found to increased linearly due 
droplet size reduced which increased spray drying while X3 level 
has least on Y1. The large positive coefficient (+1.02) of X3, 
negative coefficient (-0.90) of X2 and negative coefficient of (-1.08) 
of X2X3 suggested that atomization air pressure, spray rate and 
spray rate-atomization pressure combination respectively had 
significant effect on Y1 comparative X1 (+0.40) as per Eq. (1). This 
study indicated that atomization air pressure governed the fines 
generations, as pressure increased, fines generation increased 
proportionately. 
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Fig. 3: SEM images of enteric coated pellets of-a) F13, b) F14, c) 
F17 and d) F19 
 
The agglomerates (Y2) formation was equally influenced by the 
linear models of spray rate (X2), atomization air pressure (X3) and 
spray rate-atomization air pressure (X2X3). Three-dimensional 
surface plot (fig. 4b) indicated that when X3 increased from-1 level 
to+1 level, Y2 was found to decreased linearly due to lesser droplet 
size those avoid the pellets to pellets sticking while X2 increased 
from-1 level to+1 level, Y2 was found increased due to over wetting 
of pellets. The positive coefficient (+1.54) of X2 had major effected 
followed by negative coefficient (-1.59) of X2 and (-1.49) of X2X3 on 
Y2 as per Eq. (2) indicated X2 and X3 has equal effect of Y2. Spray rate 
above optimum over wet the pellets while atomization air pressure 






Fig. 4: Response surface plot showing the influence of process 
variables on-a) fines, b) agglomerates, and c) assay 
 
Assay was significantly influenced by the linear models of spray rate 
(X2). Fig. 4c portray the three-dimensional surface plot indicated 
that when X2 increased from-1 level to+1 level, Y3 were found to 
increased linearly could be due decreased loss of coating solution 
due to spray drying.  
The negative coefficient (-0.10) of X2 had major impact followed by 
positive coefficient (+1.02) of X2X3 on Y3 as per Eq. (3). The X3 had 
very less impact of Y3 which is not covered in equation. X2 and X3 
were the most critical process parameters found affecting on yielded 
and assay of pellets while X3 has less impact.  
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The resulting equation for all three responses Y1 (fines), Y2 
(agglomerates) and Y3 (assay) are presented below:  
Y1 =+1.33+0.40X1-0.90X2+1.02X3-1.08X2X3 ……………. (1) 
Y2 =+1.68+1.54X2-1.59X3-1.49 X2X3 ………………….……. (2) 
Y3 =+98.95-0.10X2+1.02 X2X3 …………………………...……. (3) 
Analysis of variance 
Analysis of variance (ANOVA) was performed to evaluate the 
significance of the quadratic models (linear, interactive and 
polynomial) on the responses and to estimate their quantitative 
effects. table 5 summarizes the effects of the model terms and 
associated p-values for all three responses. At a 95% confidence 
level, a model was considered significant if the p-value<0.05. The 
sign and value of the quantitative effect indicate trend and 
magnitude of the term’s influence on the response, respectively. 
Positive signs indicate an increase in the response value while 
negative signs demonstrate a decrease in the response value.  
The correlation coefficients (R2) for all three responses indicated 
good fits to the raw data. However, lower correlation coefficients 
were obtained for fines (0.883) and assay (0.780). This might be due 
to some spray dried coating material wet through filter bag and not 
considered in the calculation of percentage fines. For assay, results 
were observed in the range of 96.8-100.1% which very narrow 
range. Small change in decimal results made big error. Hence, value 
of correlation coefficients found less than 0.9. 
 
Table 5: Summary of results for testing validity of the models 
 DF SS MS (Variance) F P R2 
Fines  
Model 























































Statistical analysis for testing the validity of the models in summarized in table 5. The p-values for all the simulated responses were well below the 
significant level *(<0.05), suggesting that all the models were significantly in predicting their response values.  
 
Experimental validation of design space 
The multidimensional combination and interaction of 
independent variables and process parameters that have been 
demonstrated to provide assurance of quality is termed as the 
design space [25]. DS could be determined from the common 
region of successful operating ranges for the two responses. 
Experimental validation of DoE trials was undertaken by 
fabrication of optimized process variables. For optimized 
process variables, levels of factors which provided fines (Y1) in 
0-2% range, agglomerates (Y2) in 0-2% range and assay in 95-
105% range were screened. Fig. 5a, b and c shows the overlay 
plot for air volume 46 CFM, 58 CFM and 70 CFM respectively 
kept constant. Fig. 5d showed the overlay plot showing the 
optimized parameters suggested by DoE software to obtain the 
desired responses for process variables.  
The DS was established which was delineated in the green region in 
fig. 5d, the range of the process variable was the air volume of 46-58 
CFM, spray rate of 6-9 g/min and atomization air pressure of 1.1-1.3 
bar of the point inside the green region. 
The model predicts that process variables (represented by flag in fig. 
5d) with fines of 0 %, agglomerates of 1.14% and assay of 99.54% 
will have 58 CFM, 9 g/min and 1.30 bar of air volume, spray rate, 
and atomization air pressure respectively. After prediction by 
software, the trial was taken with set of process variables suggested 
by model and characterized. As shown in table 6 predicted and 
experimentally determined values for Y1, Y2 and Y3 were 
comparable. These values were in very close agreement and 
established the reliability of the optimization procedure. 
 
Table 6: Comparison between predicted and experimentally 
observed values for process variables 
Responses Predicted Observed 
Fines (Y1) 0.0 0.1 
Agglomerates (Y2) 1.14 1.17 
Assay (Y3) 99.54 99.45 
 
To make QbD a reality, a DS must be defined within which final 
product quality as defined by all CQAs is ensured. That space defines 
the arranges of each CPP, taking into account multivariate 
interactions. Then, the mathematical model between the CPPs and 
the CQAs provides the right combinations of CPPs that realize the 
desired quality.  
Working within the DS space is not considered as a change; however 
the movement out of the DS is considered a change and would 
normally initiate a regulatory post approval change process. DS is 
proposed by the applicant and is subject to the regulatory 
assessment and approval” [2]. The quadratic response surface of 
CQAs as a function of selected variables was given in fig. 4. A vital 
step of optimization is to achieve appropriate response functions for 
both dependencies and independences. In Design Expert, the 
desirability response values were set Y1<2%, Y2<2% and Y3 was 95-
105%. The optimized process parameters set was successfully 
extrapolated for pilot batches and it worked 100%. In future, due to 
any reason process parameters need to change for commercial 
batches then based on DS it is possible without taking the prior 
approval supplement.  
Updated risk assessment 
Following completion of process development studies, a greater 
understanding of the risks to product yield and assay associated 
with coating process been developed in DS which covered all 
validated range of process variables. Risk associated with process 
variables and mitigated discussed in fig. 2 (Pareto chart) based on 
validated design model and optimization study results. Using FMEA, 
the modes of failure can be prioritized for risk management 
purposes according to the seriousness of their consequences 
(effects), it can also be used to predict how frequently they occur 
and how easily they can be detected [26]. 
Control strategy for enteric coating process variables 
For ensuring a product of required quality of robustness and 
consistency during producing, ICH Q10 defines the control strategy 
as “a planned set of controls, derived from the understanding of 
current product and process that assures process performance and 
product quality [4]. 
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Fig. 5: Overlay plot to EC process comprised of the overlap region of ranges for the three CQAs-a) 46 cfm of air volume, b) 58 cfm of air 
volume, c) 70 cfm of air volume and d) design space 
 
 
Fig. 6: The control strategy for pantoprazole enteric coating process 
 
The normal operating ranges is CS which is defined as the upper 
and/or lower limits for the critical material attributes. In the CS, 
the parameters were routinely controlled during production in 
order to assure the reproducibility [25]. The acceptable range of 
material attributes was determined basing on the knowledge 
space from screening design and DS, the detail information was 
explained in fig. 6. 
Evaluation of industrial batches 
Scale up was performed in Pam FBE 125C (18'' Wurster) based on 
the optimized process parameters of coating process in Pam GPCG 
1.1. The results were reproduced during scale up and found 0.05% 
of fines, 0.08% of agglomerates and 99.74% of assay. The desired 
spray rate was achieved in 1 h after start coating by slowly ramp up 
the pump rpm and after wards ran the process on constant spray 
rate. The comparative SEM images of enteric coated pellets of 
optimized process parameters run at lab and scale up presented in 
fig. 7 and found same pellet surface. 
 
 
Fig. 7: SEM images of enteric coated pellets of-a) optimized 
process parameters of trial V1 b) scale up batch (PTZ40-001). 
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Successful scale-up batches 
Linear scale-up from lab scale to pilot scale assumed that the 
occupancy was the same and the distribution plate in each piece of 
equipment is geometrically similar. Additionally, ratios of air volume 
to plate area and spray rate to air volume maintained. The scale-up 
factor from Pam GPCG 1.1 to Pam FBE 125C is approximately 9-fold 
based on vendor recommendation used for successful scale up.  
CONCLUSION 
The QbD based enteric coating process development given 
promising output which used in scale up activity. Scale up of pellets 
can be possible based on complete optimization of process variables, 
understanding of risk associated with variables and implementation 
of scale-up factor calculation provided by vendor.  
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